Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECEPT: Cetirizine vs Diphenhydramine for Ocrelizumab Infusion Reactions
NCT04175834Phase 3Completed
- Start
- Feb 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetirizine in infusion-related reaction (IRR). Started Feb 2020; status: completed.
02
Drugs
cetirizine
03
Conditions
infusion-related reaction (IRR)
Beyond the preview
Go deeper on NCT04175834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04175834.